![Hans Louis Jos de Winter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Louis Jos de Winter
Plus aucun poste en cours
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jan Delcour | M | - |
Université Catholique de Louvain
| 33 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Willem Broekaert | M | - |
Université Catholique de Louvain
| 15 ans |
Frederic de Sauvage | M | - |
Université Catholique de Louvain
| 8 ans |
Johan van den Bossche | M | - |
Silicos SA
![]() Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
Roland Pirmez | M | 64 |
Université Catholique de Louvain
| 6 ans |
Bart de Moor | M | 63 |
Silicos SA
![]() Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
Gert Adam Irma Thijs | M | - |
Silicos SA
![]() Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | 7 ans |
Wilfried van Langenaeker | M | - |
Silicos SA
![]() Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | 7 ans |
Zeger Debyser | M | - |
Université Catholique de Louvain
| 7 ans |
Christine Morris | F | - |
Université Catholique de Louvain
| 6 ans |
Lieven Larmuseau | M | 62 |
Université Catholique de Louvain
| 2 ans |
Luc Gellens | M | 68 |
Université Catholique de Louvain
| 8 ans |
Armando J. Arrieta M. | M | - |
Université Catholique de Louvain
| 5 ans |
Peter Paul Godelieve Kloeck | M | 60 |
Université Catholique de Louvain
| 6 ans |
Marcos Stefan Kulka Kuperman | M | - |
Université Catholique de Louvain
| 5 ans |
Marcin Lukaszewicz | M | - |
Université Catholique de Louvain
| 5 ans |
Marcin Ziemowit Lukaszewicz | M | 57 |
Université Catholique de Louvain
| 5 ans |
Peter van Overschee | M | - |
Université Catholique de Louvain
| 5 ans |
Urbain Vandeurzen | M | 68 |
Université Catholique de Louvain
| 8 ans |
Johan Cardoen | M | 65 |
Université Catholique de Louvain
| 6 ans |
Willem Frans Alfons van Twembeke | M | 59 |
Université Catholique de Louvain
| 8 ans |
Bernard Thuysbaert | M | - |
Université Catholique de Louvain
| 4 ans |
Pascale Schobbens-Vin | F | 59 |
Université Catholique de Louvain
| 3 ans |
Onno W. Verstegen | M | 61 |
Université Catholique de Louvain
| 2 ans |
Hugues Wynants | M | - |
Université Catholique de Louvain
| 5 ans |
Geert van Haver | M | 67 |
Université Catholique de Louvain
| 2 ans |
Alexis Bernard | M | 50 |
Université Catholique de Louvain
| 5 ans |
Bert Vermeire | M | - |
Université Catholique de Louvain
| 1 ans |
Erik Vanderhaegen | M | - |
Université Catholique de Louvain
| 3 ans |
Geert Voet | M | - |
Université Catholique de Louvain
| 2 ans |
Eddy Hartung | M | 72 |
Université Catholique de Louvain
| 4 ans |
Juan-Francisco Defalque | M | 59 |
Université Catholique de Louvain
| 1 ans |
Xavier Denis | M | 52 |
Université Catholique de Louvain
| 4 ans |
Emmanuel Herve Gerard Fiévet | M | 55 |
Université Catholique de Louvain
| 4 ans |
Bai Chun Xiao | M | 76 |
Université Catholique de Louvain
| 2 ans |
Pierre Focant | M | 56 |
Université Catholique de Louvain
| 4 ans |
Matt Roswell | M | - |
Université Catholique de Louvain
| 1 ans |
Philippe Carron | M | 64 |
Université Catholique de Louvain
| 1 ans |
Marc Ernaelsteen | M | - |
Université Catholique de Louvain
| 4 ans |
Marc Van Den Neste | M | - |
Université Catholique de Louvain
| 5 ans |
Isabelle Peeters | F | - |
Université Catholique de Louvain
| 5 ans |
Maria Leonor Modesto | F | 66 |
Université Catholique de Louvain
| 3 ans |
Benoît Champluvier | M | - |
Université Catholique de Louvain
| 4 ans |
José Miguel B. Schorcht da Silva Pessanha | M | 63 |
Université Catholique de Louvain
| 1 ans |
Jean-Marc Legrand | M | - |
Université Catholique de Louvain
| 3 ans |
Rafael Vicente Correa Delgado | M | 61 |
Université Catholique de Louvain
| 1 ans |
Philippe Lamberts | M | 61 |
Université Catholique de Louvain
| 4 ans |
Piet van Riet | M | 62 |
Université Catholique de Louvain
| 1 ans |
Sylvie Duvieusart-Marquant | F | 58 |
Université Catholique de Louvain
| 3 ans |
Emanuela Bonadiman | F | 61 |
Université Catholique de Louvain
| 4 ans |
Vincent Vliebergh | M | - |
Université Catholique de Louvain
| 4 ans |
Nicolas Logé | M | 58 |
Université Catholique de Louvain
| 4 ans |
Daniel Falque | M | 60 |
Université Catholique de Louvain
| 1 ans |
Louvrier Pierre Michel | M | 51 |
Université Catholique de Louvain
| 3 ans |
Leen Deley | F | 52 |
Université Catholique de Louvain
| 4 ans |
Paul Deleu | M | 64 |
Université Catholique de Louvain
| 4 ans |
François-Myriam-J. Derbaix | M | - |
Université Catholique de Louvain
| 5 ans |
Benoît Timmermans | M | 63 |
Université Catholique de Louvain
| 3 ans |
Tiziano Brianza | M | 68 |
Université Catholique de Louvain
| 3 ans |
Jean Martin | M | 65 |
Université Catholique de Louvain
| 4 ans |
Gil Beyen | M | 62 |
Université Catholique de Louvain
| 1 ans |
Mathieu Francois Pierre Pasture | M | - |
Université Catholique de Louvain
| 4 ans |
Marc Mommaerts | M | - |
Silicos SA
![]() Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
Guy Mannaerts | M | - |
Silicos SA
![]() Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
Luc Dehaspe | M | - |
Université Catholique de Louvain
| 1 ans |
Juan Pablo Spoerer Hurtado | M | 54 |
Université Catholique de Louvain
| 4 ans |
Armando Arrieta | M | - |
Université Catholique de Louvain
| 2 ans |
Danny van D'huynslager | M | - |
Université Catholique de Louvain
| 4 ans |
Patrick Lemmens | M | 68 |
Université Catholique de Louvain
| 3 ans |
Marc Josz | M | 66 |
Université Catholique de Louvain
| 4 ans |
Marc Nolet de Brauwere | M | - |
Université Catholique de Louvain
| 4 ans |
Eric Merkel-Sobotta | M | 60 |
Université Catholique de Louvain
| 3 ans |
Daniel Hugues Jules Gauthier | M | 67 |
Université Catholique de Louvain
| 1 ans |
Pierre de Muelenaere | M | 65 |
Université Catholique de Louvain
| 3 ans |
Pierre Simard | M | 59 |
Université Catholique de Louvain
| 2 ans |
Jan Gesquière | M | 63 |
Université Catholique de Louvain
| 4 ans |
Dirk de Backer | M | 53 |
Université Catholique de Louvain
| 5 ans |
Vincent de Dorlodot | M | 59 |
Université Catholique de Louvain
| 3 ans |
Eduardo de Salles Bartolomeo | M | 60 |
Université Catholique de Louvain
| 2 ans |
Paul Embrechts | M | 71 |
Université Catholique de Louvain
| 8 ans |
Ricardo Prada Silvy | M | - |
Université Catholique de Louvain
| 3 ans |
Jean Eylenbosch | M | 65 |
Université Catholique de Louvain
| 3 ans |
Li Liu | M | 69 |
Université Catholique de Louvain
| 2 ans |
Peter Raeymaeckers | M | - |
Université Catholique de Louvain
| 4 ans |
Benoît Godts | M | 68 |
Université Catholique de Louvain
| 3 ans |
Léon Baron Bekaert | M | 66 |
Université Catholique de Louvain
| 4 ans |
Karel Lannoo | M | - |
Université Catholique de Louvain
| 1 ans |
Ghassan Hanna Sulaiman Tarazi | M | 60 |
Université Catholique de Louvain
| 2 ans |
Eric Conrads | M | - |
Université Catholique de Louvain
| 4 ans |
Annick van Overstraeten | F | 58 |
Université Catholique de Louvain
| 1 ans |
Bertrand Désirand | M | - |
Université Catholique de Louvain
| 4 ans |
Eric Tancré | M | 64 |
Université Catholique de Louvain
| 4 ans |
Grégoire Dallemagne | M | 51 |
Université Catholique de Louvain
| 4 ans |
Joris Coppye | M | 58 |
Université Catholique de Louvain
| 4 ans |
Philippe Maeckelberghe | M | 64 |
Université Catholique de Louvain
| 2 ans |
Etienne Robert Christian Ferain | M | - |
Université Catholique de Louvain
| 3 ans |
Carlo Bernardus Ghislain Groffils | M | - |
Université Catholique de Louvain
| 4 ans |
Dieter Penninckx | M | - |
Université Catholique de Louvain
| 5 ans |
Frédéric Adam | M | - |
Université Catholique de Louvain
| 4 ans |
Stanislas Kervyn | M | - |
Université Catholique de Louvain
| 5 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Belgique | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Hans Louis Jos de Winter
- Réseau Personnel